Literature DB >> 24913287

An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery.

Muzaffer Saglam1, Ahmet Sarici, Vania Anagnostakou, Bulent Yildiz, Naci Kocer, Civan Islak, Osman Kizilkilic.   

Abstract

INTRODUCTION: Superselective intra-arterial chemotherapy (IAC) in retinoblastoma has recently become a popular treatment option. In this study, we purposed to investigate the effectiveness of the technique of "retrograde approach through the posterior communicating artery to the ophthalmic artery (OA)" for IAC.
METHODS: A total of 12 unilateral retinoblastomas were treated with IAC in 29 sessions from October 2011 to November 2013. Of the 12 patients, 6 were male and 6 were female, with ages ranging from 12 to 72 months with a median age of 27.6 months. Left-to-right ratio for affected eye was 6/6. In the first 4 patients, we used the ipsilateral internal carotid artery (ICA) to reach the OA of the affected globe (10 sessions). Then, we used the vertebral artery, basilary artery, ipsilateral/contralateral P1 segment of the posterior cerebral artery, and ipsilateral/contralateral posterior communicating artery, respectively, to reach inside the OA at next 15 sessions.
RESULTS: At ipsilateral approach, fluoroscopy total time ranged from 16 to 34 min (mean 21.5 min), and the angle between ophthalmic segment of the ICA and proximal segment of the OA was ranged between 34° and 77° with an average angle of 53.4°. At retrograde approach, fluoroscopy total time ranged from 3 to 12 min (mean 7.5 min), and the angle between ophthalmic segment of the ICA and proximal segment of the OA was ranged between 147° and 178° with an average angle of 148.3°.
CONCLUSION: Retrograde approach makes the IAC procedure easier in retinoblastoma patients and shortens the fluoroscopy time.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24913287     DOI: 10.1007/s00234-014-1388-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.

Authors:  Chi-Tuan Pham; Raphaël Blanc; L Lumbroso-Le Rouic; Livia Lumbroso-Le Rouic; Silvia Pistocchi; Bruno Bartolini; Michel Piotin
Journal:  Neuroradiology       Date:  2011-11-18       Impact factor: 2.804

Review 2.  Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Clin Exp Ophthalmol       Date:  2010-03-25       Impact factor: 4.207

3.  Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.

Authors:  Ahmet Sarici; Osman Kizilkilic; Tiraje Celkan; Safa Gode
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

4.  Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.

Authors:  David H Abramson; Ira J Dunkel; Scott E Brodie; Brian Marr; Y Pierre Gobin
Journal:  Arch Ophthalmol       Date:  2010-03

5.  Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment.

Authors:  Carol L Shields; Swathi Kaliki; Sanket U Shah; Carlos G Bianciotto; Pascal Jabbour; Jerry A Shields
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

6.  Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.

Authors:  Y Pierre Gobin; Ira J Dunkel; Brian P Marr; Scott E Brodie; David H Abramson
Journal:  Arch Ophthalmol       Date:  2011-02-14

Review 7.  Retinoblastoma: what is new in 2007-2008.

Authors:  Amy C Schefler; David H Abramson
Journal:  Curr Opin Ophthalmol       Date:  2008-11       Impact factor: 3.761

8.  A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Authors:  David H Abramson; Ira J Dunkel; Scott E Brodie; Jonathan W Kim; Y Pierre Gobin
Journal:  Ophthalmology       Date:  2008-03-14       Impact factor: 12.079

9.  Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma.

Authors:  Y Pierre Gobin; Ira J Dunkel; Brian P Marr; Jasmine H Francis; Scott E Brodie; David H Abramson
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results.

Authors:  Brian P Marr; Scott E Brodie; Ira J Dunkel; Y Pierre Gobin; David H Abramson
Journal:  Br J Ophthalmol       Date:  2012-08-03       Impact factor: 5.908

View more
  2 in total

1.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

2.  Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma.

Authors:  Giancarlo Saal-Zapata; Rodolfo Rodríguez; Aaron Rodriguez-Calienes; Raúl Cordero
Journal:  Neuroradiol J       Date:  2021-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.